|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3850 EUR | -0.39% |
|
+1.05% | +29.19% |
| 07-01 | Nicox Submits NCX 470 New Drug Application In The United States | CI |
| 07-01 | Nicox files U.S. marketing approval application |  |
Evolution of the Average Target: Nicox SA
Evolution of the Target Price: Nicox SA
Changes in Analyst Recommendations: Nicox SA
eff8e.xNLoUvlXtigqtyrgX2fwUoruwMrXLZeqX5mwW8zUI6E.sbHaNNQm9Wxtg3iDZ1-YAc2IrJybFfGHbujlLuGMUe2F640ZiALDT3DiEg~fcdffc3ca46e506227816f06556457d5
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +159.74% | |||
| +7.12% | |||||
| +4.41% | |||||
| +10.1% | |||||
| -15.67% | |||||
| +63.72% | |||||
| - | - | -34.62% | |||
| +86.21% | |||||
| +31.04% | |||||
| Average | +34.67% | |||||
| Weighted average by Cap. | +7.26% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.3850EUR
Average target price
1.000EUR
Spread / Average Target
+159.74%
High Price Target
1.000EUR
Spread / Highest target
+159.74%
Low Price Target
1.000EUR
Spread / Lowest Target
+159.74%
Analyst Consensus Detail
Consensus revision (last 18 months)
SellBuy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.3850EUR
Average target price
1.000EUR
Spread / Average Target
+159.74%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALCOX Stock
- Consensus Nicox SA
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
